Academy of Pharmaceutical

Sciences
John Wahlich, Jayne Lawrence, Eddie French
1
APS Mission and Aims

Mission:
Championing innovation and opportunity in
Pharmaceutical Sciences for the delivery of medicines
Aims
Promote the Pharmaceutical Sciences to stakeholders
to facilitate understanding and achieve engagement
Share learning, drive collaboration, partnership and
innovation
Deliver insights into industry and academic roles for
emerging scientists
2
APS Strategic Themes
The mission of the Academy of Pharmaceutical Sciences is to champion innovation
and opportunity in Pharmaceutical Sciences for the delivery of medicines.
Influence
Policy
More investment in Pharm Sciences in UK
APS view sought by policy makers and TSB
APS recognised as only professional group representing Pharm Sciences
Senior Executives recognise the influence from and return on investment in APS
Promote
Careers
Strengthen training and development of young scientists by supporting early career development
Build APS membership amongst students
Mentor post-grads and PhDs in academia
Establish connection with TSB for research projects
Further
Scientific
knowledge
Support Focus Groups to further scientific knowledge
Increase quantity of hard outputs/papers
Influence direction of research funding
Represent
Pharma
Sciences
Establish APS reputation for balanced independent view of Pharm Sciences in UK
Extend representation through engagement with pharma mid tier, CROs, CMOs and SMEs
Increase membership amongst pharma scientist population
APS Enablers
Increase
organisational
membership
Robust
sponsorship
income streams
Clear APS brand
definition


3
Focus Group Current Chairperson(s)
Emerging Scientists and
Development
Helen Barker / Claire
Thompson / Geoff Davison
Biomolecules and Vaccines Kevin King
Biopharmaceutics and oral drug
delivery
Mark McAllister
Inhalation Eddie French
Material Sciences Michael Leane
Pharmacognosy Michael Heinrich
Process Engineering, Product
Formulation and Manufacturing
Kendal Pitt
Anti-infectives (Microbiology) Brendan Gilmore
Skin Forum Majella Lane
APS Focus Groups
4
APS
The APS is a not-for-profit organisation funded
through membership and sponsorship
Of attendees today less than 25% are
members of APS
If you like what were doing and want to
support the Pharmaceutical Sciences in the UK
join the APS!
60 / year or 15 for students
http://www.apsgb.co.uk/default.asp
5
Medicines for Older Adults
Meeting Stevenage 13 March 2013
Medicines for older adults: Learning from practice to
develop patient centric drug products
Jointly organised by the Academy of Pharmaceutical
Sciences (APS), the Geriatric Medicine Society and UCL
School of Pharmacy
The event created the platform to discuss the provision
of medicines for older adults from a pharmaceutical
sciences perspective
Meeting commentary Int J Pharm. 2013 Nov
1;456(1):251-7. doi: 10.1016/j.ijpharm.2013.07.038.
Epub 2013 Aug 3. (35 references)

6
Medicines for Older Adults
Meeting discussed
Demographics of older adults
Physiological aspects of ageing
Medicines and ageing from a clinical, pharmacy and regulatory
perspective
ADRs, polypharmacy, adherence, formulation and delivery aspects
Conclusion
Parallels with paediatric medicines
More could be done to improve the delivery of medicines to older
adults
Opportunity for collaboration to achieve this

The use of medications in older patients is arguably the single
most important health care intervention in the industrialized
world. (Avorn 2010)
Avorn, J., 2010. Medication Use in Older Patients: Better Policy Could Encourage Better Practice. JAMA 304,
1606-1607.
7
Age Related Medicines Focus Group
APS can provide the framework for collaboration
Web site
Access to membership and Linked-in contact networks
Links with other Focus Groups
Support (financial and organisational) for workshops / conferences /
symposia
APS Pharm Sci 2014 Conference September
Potential for session at FIP Conference Bangkok (August 2014)
Outcome from meeting
Ownership going forward
Committee identified
Next steps agreed
Its your meeting were here to facilitate!
8